FDA Inspection Consulting | Mock Audits & Remediation Experts

Expert FDA Inspection
Preparation & Support

Ensure your facility passes FDA inspections with confidence. Our experienced team provides comprehensive preparation, documentation review, and on-site support.

Don’t wait until the last minute. Our proactive approach ensures your facility is always inspection-ready.

Industries We Serve

Comprehensive FDA Compliance Services

From preparation to post-inspection support, we provide end-to-end solutions to ensure your facility meets all FDA requirements and maintains compliance.

Pre-Inspection Preparation

Comprehensive facility audits, documentation review, and gap analysis to ensure complete readiness.

On-Site Inspection Support

Expert consultants present during inspections to provide guidance and ensure smooth interactions with FDA officials.

CAPA Development

Corrective and Preventive Action plan development for addressing inspection findings and preventing recurrence.

Training Programs

Staff training on FDA regulations, GMP compliance, and inspection preparedness for your entire team.

Documentation Systems

Design and implementation of robust documentation systems that meet FDA requirements and best practices.

24/7 Emergency Support

Round-the-clock support for urgent compliance questions and emergency inspection notifications.

Every facility is unique. We provide tailored consulting services to address your specific compliance challenges and regulatory requirements.

Your Trusted Partner in

FDA Compliance

With over 15 years of experience in FDA regulatory compliance, our team of former FDA inspectors and industry experts has helped hundreds of facilities successfully navigate complex regulatory requirements.

We understand the challenges you face because we’ve been there. Our practical, results-driven approach ensures your facility not only passes inspections but maintains ongoing compliance excellence.

Former FDA inspectors on our team with insider knowledge
Proven methodologies tested across diverse industries
Ongoing support to maintain compliance between inspections

Our team brings decades of combined experience from both regulatory and industry perspectives.

500+

Facilities Served

100%

Success Rate

15+

Years Experience

24/7

Support Available

Our Blogs

A researcher in a lab suit and blue gloves points to a computer screen displaying an "Electronic Audit Trail" with verified and anomalous data, in a clinical setting.

Inspections

Data Integrity During FDA Inspections: The Questions Investigators Ask Most

In the high-stakes world of pharmaceutical and medical device manufacturing, data is the most valuable asset. This 2026 guide breaks down the core components of an FDA data integrity inspection, identifying the specific questions investigators prioritize during audits. From ALCOA+ principles to electronic audit trails, discover how to protect your facility from 483 observations and warning letters.

May 10, 2026 No Comments

A scientist in a sterile suit works with pink liquid in a lab hood, a futuristic holographic DNA display next to them.

Inspections

FDA Cell and Gene Therapy Inspections: What Investigators Are Looking For

As the frontier of regenerative medicine expands, navigating cell and gene therapy FDA inspections has become a critical milestone for biotech innovators. This 2026 guide explores what investigators prioritize—from aseptic processing and viral clearance to complex chain-of-identity protocols. Learn how to align your quality systems with CBER expectations and ensure your advanced therapy reaches the market securely.

May 10, 2026 No Comments

Aik modern laboratory ke conference room mein aik male aur female executive transparent glass tablets par data aur complex diagrams dekhte hue discussion kar rahe hain. Background mein laboratory equipment aur scientists nazar aa rahe hain.

Inspections

What FDA Investigators Can Legally Ask for During an Inspection

Navigating a regulatory audit requires a precise understanding of the legal boundaries governing federal oversight. This comprehensive 2026 guide explores the extent of FDA inspection authority, identifying exactly what investigators can legally request, which records are shielded from review, and how manufacturers can protect their interests while remaining fully compliant during on-site assessments.

May 9, 2026 No Comments

Aik modern lab mein professional scientist (khatoon) blue gloves aur safety glasses pehne pipette se kaam kar rahi hain. Saath mein advanced medical research equipment aur un ki screen par graphs hain.

Warning Letters

FDA Dietary Supplement Inspections: GMP Violations Companies Miss Most Often

As regulatory scrutiny intensifies, navigating a dietary supplement FDA inspection requires a deep dive into 21 CFR 111 compliance. This 2026 guide highlights the most frequent GMP violations—from identity testing failures to inadequate batch records—and provides actionable strategies for manufacturers and distributors to remain audit-ready in an increasingly data-driven environment.

May 9, 2026 No Comments

A professional woman in a cleanroom examines a complex tool in front of a transparent augmented reality screen displaying a "GS1 13485 & FDA QMSR Alignment Checklist." Robotic arms are visible in the background.

Actions

FDA Medical Device Inspections: QS Regulation vs QMSR Explained

The medical device industry is facing a pivotal shift as the FDA transitions from the legacy Quality System Regulation (21 CFR 820) to the new Quality Management System Regulation (QMSR). This comprehensive guide explains the core differences, the alignment with ISO 13485:2016, and what manufacturers must prioritize to ensure a successful FDA QMSR inspection outcome in 2026.

May 9, 2026 No Comments

Clean room scenario: a lab technician in gloves holds a transparent holographic tablet with green and grey graphs and data, in front of high-tech manufacturing equipment and a large stainless steel bioreactor.

Inspections

FDA Inspection Readiness for CDMOs: The Biggest Mistakes Sponsors Still Make

Ensuring regulatory compliance requires more than just hiring a third-party manufacturer. This guide explores the critical gaps in CDMO FDA inspection readiness, highlighting the common mistakes sponsors make during the oversight process. Learn how to strengthen your quality agreements, improve data integrity, and ensure your external partners remain audit-ready in the evolving 2026 landscape.

May 9, 2026 No Comments

Get Expert FDA Consultation

Don’t face your next FDA inspection alone. Contact our experts today for a confidential consultation and ensure your facility is ready.

If you’ve received an FDA inspection notice, don’t panic. Our rapid response team can help you prepare quickly and effectively.

FDA Inspections

Consulting and Compliance

Expert FDA Inspection
Preparation & Support

Industries We Serve

Biologics

Cosmetics

Dietary Supplement

Medical Devices

Pet Food & Animal Health

Pharmaceuticals